<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vialard F</submitter><funding>Fonds de Recherche du Québec - Santé</funding><funding>India-Canada Centre for Innovative Multidisciplinary Partnerships to Accelerate Community Transformation and Sustainability</funding><funding>Canadian Institutes of Health Research</funding><pagination>467-473</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12573389</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>101(7)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Across Canada, in the last decade, incidence rates of sexually transmitted and blood-borne infections (STBBI) have peaked (syphilis) or plateaued (hepatitis C virus (HCV) and HIV). Key populations (gay, bisexual and other men who have sex with men, trans and gender-diverse people, and people who use injection drugs) are at greater risk for these STBBIs, so correctly predicting risk before screening potentially infected individuals is crucial. We developed and validated a diagnostic clinical risk prediction model (CRPM) estimating HIV, HCV and syphilis risk for two key populations in two Canadian provinces.&lt;h4>Methods&lt;/h4>We used 20 variables and STBBI test results from a cross-sectional study evaluating multiplexed testing (detection of coinfections) in New Brunswick and</pubmed_abstract><journal>Sexually transmitted infections</journal><pubmed_title>Developing and validating a Bayesian clinical risk prediction model for three sexually transmitted infections in key populations from two Canadian provinces.</pubmed_title><pmcid>PMC12573389</pmcid><funding_grant_id>PJT153149</funding_grant_id><funding_grant_id>324154</funding_grant_id><funding_grant_id>252845</funding_grant_id><funding_grant_id>3072</funding_grant_id><pubmed_authors>Materniak S</pubmed_authors><pubmed_authors>Dumont Blais A</pubmed_authors><pubmed_authors>Vialard F</pubmed_authors><pubmed_authors>Pant Pai N</pubmed_authors><pubmed_authors>Bartlett S</pubmed_authors><pubmed_authors>Webster D</pubmed_authors><pubmed_authors>Nair S</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Developing and validating a Bayesian clinical risk prediction model for three sexually transmitted infections in key populations from two Canadian provinces.</name><description>&lt;h4>Objectives&lt;/h4>Across Canada, in the last decade, incidence rates of sexually transmitted and blood-borne infections (STBBI) have peaked (syphilis) or plateaued (hepatitis C virus (HCV) and HIV). Key populations (gay, bisexual and other men who have sex with men, trans and gender-diverse people, and people who use injection drugs) are at greater risk for these STBBIs, so correctly predicting risk before screening potentially infected individuals is crucial. We developed and validated a diagnostic clinical risk prediction model (CRPM) estimating HIV, HCV and syphilis risk for two key populations in two Canadian provinces.&lt;h4>Methods&lt;/h4>We used 20 variables and STBBI test results from a cross-sectional study evaluating multiplexed testing (detection of coinfections) in New Brunswick and</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T09:46:27.304Z</modification><creation>2026-05-15T03:12:46.323Z</creation></dates><accession>S-EPMC12573389</accession><cross_references><pubmed>40274402</pubmed><doi>10.1136/sextrans-2024-056286</doi></cross_references></HashMap>